230 related articles for article (PubMed ID: 19136200)
1. Process in the mechanisms of endostatin combined with radiotherapy.
Zhuang HQ; Yuan ZY
Cancer Lett; 2009 Sep; 282(1):9-13. PubMed ID: 19136200
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
5. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
6. Antitumor interaction of short course endostatin and ionizing radiation.
Greenberger JS
Cancer J; 2000; 6(5):279-81. PubMed ID: 11079164
[No Abstract] [Full Text] [Related]
7. Endostatin: the logic of antiangiogenic therapy.
Abdollahi A; Hlatky L; Huber PE
Drug Resist Updat; 2005; 8(1-2):59-74. PubMed ID: 15939343
[TBL] [Abstract][Full Text] [Related]
8. Vascular damaging agents.
Patterson DM; Rustin GJ
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
[TBL] [Abstract][Full Text] [Related]
9. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
10. New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective.
Awada A; Mano M; Hendlisz A; Piccart M
Expert Rev Anticancer Ther; 2004 Feb; 4(1):53-60. PubMed ID: 14748657
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
Horsman MR; Siemann DW
Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
[TBL] [Abstract][Full Text] [Related]
12. Endostatin therapy reveals a U-shaped curve for antitumor activity.
Tjin Tham Sjin RM; Naspinski J; Birsner AE; Li C; Chan R; Lo KM; Gillies S; Zurakowski D; Folkman J; Samulski J; Javaherian K
Cancer Gene Ther; 2006 Jun; 13(6):619-27. PubMed ID: 16456550
[TBL] [Abstract][Full Text] [Related]
13. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy.
Mazeron R; Anderson B; Supiot S; Paris F; Deutsch E
Cancer Treat Rev; 2011 Oct; 37(6):476-86. PubMed ID: 21546163
[TBL] [Abstract][Full Text] [Related]
14. Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment.
Xu F; Ma Q; Sha H
Crit Rev Ther Drug Carrier Syst; 2007; 24(5):445-92. PubMed ID: 18197781
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis inhibitors and radiation therapy: from biology to clinical practice].
Mazeron R; Azria D; Deutsch E
Cancer Radiother; 2009 Oct; 13(6-7):568-73. PubMed ID: 19695932
[TBL] [Abstract][Full Text] [Related]
16. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
Itasaka S; Komaki R; Herbst RS; Shibuya K; Shintani T; Hunter NR; Onn A; Bucana CD; Milas L; Ang KK; O'Reilly MS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):870-8. PubMed ID: 17293237
[TBL] [Abstract][Full Text] [Related]
17. Radiation combined with antiangiogenic and antivascular agents.
O'Reilly MS
Semin Radiat Oncol; 2006 Jan; 16(1):45-50. PubMed ID: 16378906
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic tumor markers, antiangiogenic agents and radiation therapy.
Chan LW; Camphausen K
Expert Rev Anticancer Ther; 2003 Jun; 3(3):357-66. PubMed ID: 12820778
[TBL] [Abstract][Full Text] [Related]
19. Endostatin derivative angiogenesis inhibitors.
Zheng MJ
Chin Med J (Engl); 2009 Aug; 122(16):1947-51. PubMed ID: 19781376
[TBL] [Abstract][Full Text] [Related]
20. The interaction of radiation therapy and antiangiogenic therapy.
O'Reilly MS
Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
